Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Completed 7Active not recruiting 3Withdrawn 2Unknown 2Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 4Breast Neoplasms 3Sarcoma 2Neoplasms 2Glioblastoma 2Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Brain Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Localized Resectable Adult Primary Liver Cancer 1Jaundice 1Esophageal Neoplasms 1Duodenal Neoplasms 1Colonic Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1Childhood Brain Neoplasm 1Carcinoma, Hepatocellular 1Bites and Stings 1Biliary Tract Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

nimotuzumab 4Paclitaxel 3Surgical Procedures, Operative 2Cisplatin 2sintilimab 1pembrolizumab 1monalizumab 1epacadostat 1Taxes 1TP protocol 1Saline Solution 1Radiation 1Oxaliplatin 1Nimodipine 1Metabolic Networks and Pathways 1Fluorouracil 1Biopsy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Esophageal Squamous Cell Carcinoma × Surgical Procedures, Operative × Clear all
NCT02272699 2021-03-18

Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma

Peking University

Phase 2/3 Withdrawn
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03307941 2017-12-19

ARTEMIS-Eso

Jules Bordet Institute

Phase 1/2 Withdrawn
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡